Federal officials on Thursday approved a new type of pain drug designed to eliminate the risks of addiction and overdose ...

Federal officials on Thursday approved a new type of pain drug designed to eliminate the risks of addiction and overdose ...

An online-based mindfulness treatment program significantly reduced opioid craving among participants with opioid use disorder results from a randomized clinical trial published in JAMA Network Open ...

Reversing opioid overdoses in rats using a drug that does not enter the brain prevents the sudden and severe withdrawal symptoms associated with therapeutics that target the central nervous system.

Around two-thirds of people relapse within 30 days after being discharged from residential treatment. An app could help them ...

During the COVID-19 pandemic, when fentanyl overdoses surged, doctors were desperate to find ways of helping their patients.

The nonaddictive painkiller suzetrigine (Journavx) is as effective for acute pain as a common opioid treatment ...

The program's expansion is being funded by money Orange County received through national legal settlements with opioid ...

The prescription pills, sold under the brand name Journavx and made by Vertex Pharmaceuticals, are taken twice a day and ...

WASHINGTON (AP) — Federal officials on Thursday approved a new type of pain pill designed to eliminate the risks of addiction and overdose associated with opioid medications like Vicodin and ...

A participant in the drug trial for Journavx said it eliminated her pain without making her feel loopy or nauseous ...

The New York State health department is underscoring the importance of addiction medication in ending the opioid crisis.